Ibrahim Kassis News Today

/PRNewswire/ -- NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat myelin-related neurodegenerative...

Nathan Jeffay is The Times of Israels health and science correspondent An illustration of the impact of multiple sclerosis on the brain. On the left, a brain with white areas denoting MS damage. On the upper right, close-up of regular myelin, and below, damaged myelin. (wildpixel via iStock by Getty Images) Clinical trials for a new stem cell treatment have “frozen” the progression of multiple sclerosis, and left some patients in better condition than before they were injected, even ditchi...